Teva successfully priced $2.3 billion senior notes to fund tender offers and repay debt

From GlobeNewswire: 2025-05-20 17:22:00

Teva Pharmaceutical Industries Ltd. successfully upsized its offering and priced approximately $2.3 billion of senior notes. The proceeds will fund tender offers for various senior notes, pay fees, and repay outstanding debt upon maturity. The Notes consist of €1 billion EUR-denominated Senior Notes, $500 million USD-denominated Senior Notes, and $700 million USD-denominated Senior Notes. Settlement is expected on May 28, 2025. The offering was made through an effective shelf registration statement. Teva operates globally to deliver medicines and advance health. Forward-looking statements caution of risks and uncertainties. Distribution of this press release is restricted in certain jurisdictions.



Read more at GlobeNewswire: Teva Announces Successful Upsizing and Pricing of